Endocrine System Diseases  >>  taspoglutide (BIM51077)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
taspoglutide (BIM51077) / Ipsen
NCT00811460: A Study of Taspoglutide in Type 2 Diabetic Patients

Completed
1
18
Europe
Placebo, taspoglutide
Hoffmann-La Roche
Diabetes Mellitus Type 2
08/09
08/09

Download Options